Helsinki:ORNBV

337,000 Orion Corporation A shares converted into B shares

August 20, 2025 02:00 ET  | Source: Orion Oyj ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO…

2 weeks ago

Darolutamide receives EU approval in third indication for patients with advanced prostate cancer

July 21, 2025 03:30 ET  | Source: Orion Oyj ORION CORPORATION PRESS RELEASE 21 JULY 2025 at 10:30 EEST           Darolutamide…

1 month ago